ibrexafungerp citrate

Ibrexafungerp citrate is a triterpenoid antifungal. Similarly to echinocandins, it inhibits the synthesis of 1,3-β-d-glucan. However, it binds to a different site on the enzyme than echinocandins, resulting in limited cross-resistance. Ibrexafungerp exerts concentration-dependent fungicidal activity against Candida species and retains in vitro activity against most fluconazole-resistant strains.

Ibrexafungerp (MK 3118) 是一种具有口服活性的 β-1,3-葡聚糖合成抑制剂，具有抗真菌活性，通过抑制β-1,3-D 葡聚糖合成酶来损害真菌细胞壁的完整性。Ibrexafungerp 可用于研究真菌感染。